Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Turn Therapeutics Inc. (TTRX) had Normalized Pre-Tax Income of $-3.19M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-3.19M |
|
-- |
|
-- |
|
$5.86M |
|
$-5.86M |
|
$2.66M |
|
$-3.19M |
|
|
Normalized Pre-Tax Income |
$-3.19M |
$-3.19M |
|
$-3.19M |
|
$-3.19M |
|
$-3.19M |
|
$-5.86M |
|
$-5.31M |
|
27.72M |
|
27.72M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$5.20M |
|
-- |
|
$6.97M |
|
$12.16M |
|
$6.00M |
|
-- |
|
$1.47M |
|
$7.48M |
|
$4.69M |
|
$3.76M |
|
$4.69M |
|
29.45M |
|
| Cash Flow Statement Financials | |
$-2.56M |
|
$-0.15M |
|
$6.92M |
|
$0.87M |
|
$5.08M |
|
$4.20M |
|
$0.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.87 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-68.15% |
|
-84.85% |
|
-26.26% |
|
-68.15% |
|
$0.16 |
|
$-0.09 |
|
$-0.09 |
|